Ye Li

机构：South China Normal University, First Affiliated Hospital of Zhengzhou University · ORCID：0000-0002-8150-5056

发表论文 61 篇 · 总被引 1485 次 · h-index 17

代表论文

• Engineering CRISPR System‐Based Bacterial Outer Membrane Vesicle Potentiates T Cell Immunity for Enhanced Cancer Immunotherapy (2025 · Advanced Materials · 被引 28)
• OA04.05 SHR-A1921, A TROP-2 Targeted Antibody-Drug Conjugate (ADC), In Patients (pts) with Advanced Small-Cell Lung Cancer (SCLC) (2024 · Journal of Thoracic Oncology · 被引 16)
• A Multifunctional Fe-EGCG@RSL3 Nanomedicine Synergizes Ferroptosis Induction and Tumor Microenvironment Remodeling for Enhanced Bladder Cancer Immunotherapy (2025 · Research · 被引 12)
• A novel flexible phase change fibrous composite membrane with tunable thermal management capability for highly sensitive and physically comfortable strain sensor (2025 · Composites Communications · 被引 11)
• Direct cGAMP Delivery via Iron Oxide Nanoparticles for Enhanced STING Activation and Durable Antitumor Immunity (2025 · Nano Letters · 被引 8)
• Mortality and cardiac arrest rates of emergency surgery in developed and developing countries: a systematic review and meta-analysis (2024 · BMC Anesthesiology · 被引 7)